fludarabine phosphate has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deeg, HJ; Furlong, T; Heimfeld, S; McCune, JS; O'Donnell, PV; Storer, B; Wang, J; Woodahl, EL | 1 |
| Hotta, T; Minami, H; Morishima, Y; Ogawa, Y; Ogura, M; Sasaki, Y; Seriu, T; Tobinai, K; Watanabe, T | 1 |
| Hayashi, M; Hotta, T; Ishizawa, K; Matsuno, Y; Matsusako, M; Minami, H; Mori, S; Morishima, Y; Nakamura, S; Nawano, S; Ogawa, Y; Ogura, M; Ohashi, Y; Seriu, T; Taniwaki, M; Terauchi, T; Tobinai, K; Utsunomiya, A; Watanabe, T | 1 |
| Alexanian, R; Dimopoulos, MA; Kantarjian, H; Keating, M; Weber, DM | 1 |
| Child, JA; Johnson, PW; Johnson, SA; Morgan, GJ; Prentice, AG; Rule, S; Smith, GM; Tollerfield, SM; Wareham, E | 1 |
| Childs, CC; Freireich, EJ; Kantarjian, H; Keating, MJ; Koller, C; McCredie, KB; O'Brien, S; Schachner, J; Talpaz, M | 1 |
5 trial(s) available for fludarabine phosphate and Recrudescence
| Article | Year |
|---|---|
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.
Topics: Adult; Aged; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Pharmacological; Busulfan; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Recurrence; Survival Rate; Vidarabine Phosphate | 2012 |
Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Vidarabine Phosphate | 2006 |
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Vidarabine Phosphate | 2006 |
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recurrence; Salvage Therapy; Survival Rate; Vidarabine Phosphate | 2000 |
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Survival Rate; Vidarabine Phosphate | 1991 |
1 other study(ies) available for fludarabine phosphate and Recrudescence
| Article | Year |
|---|---|
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Drug Resistance; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1994 |